...
首页> 外文期刊>American journal of rhinology >Outcome in patients with chronic sinusitis after the minimally invasive sinus technique.
【24h】

Outcome in patients with chronic sinusitis after the minimally invasive sinus technique.

机译:微创鼻窦手术后慢性鼻窦炎患者的预后。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Controversy persists regarding the use of minimally invasive sinus techniques (MIST) to treat chronic sinusiris primarily because of an absence of comparative outcome data. METHODS: In this prospective study of 85 patients with chronic sinusitis treated surgically with MIST, the long-term postoperative outcome was assessed using the duration-based Chronic Sinusitis Survey (CSS) quality of life instrument. Patient age ranged from 4 to 81 years old (mean age, 42 +/- 16.7 years). Forty-three subjects were male patients and 42 were female patients. Mean follow-up time was 23.8 +/- 2.2 months. RESULTS: At follow-up, there was a 124.0% improvement in the mean CSS symptom score (p < 0.00001), a 30.1% improvement in the mean CSS medication score (p < 0.00001), and a 62.0% improvement in the mean CSS total score (p < 0.00001). An overall improvement was found in 78.8% of patients; 12.9% of patients were worse and 8.2% of patients were unchanged. Thirty-four patients (40.0%) had postsurgical CSS total scores within the normative interquartile range obtained in healthy controls. Twenty-six of these patients had postsurgical scores that actually surpassed the mean normative CSS total score. Before follow-up evaluation, 5 of the 85 patients (5.9%) had revision surgery after the initial procedure. All had revision MIST procedures and all were found to have an overall improvement at the time of follow-up. CONCLUSION: We conclude that MIST significantly improves the outcome in patients with chronic sinusitis and should strongly be considered as the initial surgical option for such patients.
机译:背景:关于微创鼻窦技术(MIST)治疗慢性鼻窦炎的争论一直存在,这主要是因为缺乏比较的结果数据。方法:在这项对85例经MIST手术治疗的慢性鼻窦炎患者的前瞻性研究中,使用基于持续时间的慢性鼻窦炎调查(CSS)生活质量工具对长期术后结局进行了评估。患者年龄为4至81岁(平均年龄为42 +/- 16.7岁)。 43名受试者为男性患者,42名女性患者。平均随访时间为23.8 +/- 2.2个月。结果:随访时,平均CSS症状评分改善了124.0%(p <0.00001),平均CSS药物评分改善了30.1%(p <0.00001),平均CSS改善了62.0%总分(p <0.00001)。在78.8%的患者中发现了总体改善; 12.9%的患者病情恶化,而8.2%的患者病情未变。 34名患者(40.0%)的手术后CSS总分在健康对照组获得的标准四分位数范围内。这些患者中有26位的手术后评分实际上超过了平均规范CSS总评分。在随访评估之前,85例患者中有5例(5.9%)在初始手术后进行了翻修手术。全部都有修订的MIST程序,并且在随访时发现全部都有改进。结论:我们得出的结论是,MIST可以显着改善慢性鼻窦炎患者的预后,因此,强烈建议将MIST作为此类患者的初始手术选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号